Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INO-5401 |
Trade Name | |
Synonyms | INO5401|INO 5401 |
Drug Descriptions |
INO-5401 is a synthetic DNA immunotherapy that delivers plasmids to express three tumor associated antigens (WT1, PSMA (FOLH1), and TERT), which stimulates the immune system to attack cells expressing these antigens (AACR; Cancer Res 2019;79(13 Suppl):Abstract nr CT114). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C148480 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + INO-5401 + INO-9012 | Atezolizumab INO-5401 INO-9012 | 0 | 1 |
Cemiplimab + INO-5401 + INO-9012 + Temozolomide | Cemiplimab INO-5401 INO-9012 Temozolomide | 0 | 1 |
INO-5401 | INO-5401 | 0 | 1 |
INO-5401 + INO-9012 | INO-5401 INO-9012 | 0 | 1 |